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Summary
Objective: To determine the seroprevalence of human immunodeficiency virus (HIV), hepatitis B
and C viruses (HBV, HCV), and herpes simplex virus type 2 (HSV-2) in the tribal population of
central India.
Methods: A community-based cross-sectional survey was carried out in the tribal population of
Jabalpur district. Blood samples were drawn from 326 patients with sexually transmitted
infections (STIs) and 526 randomly selected adults. These were tested for HIV, HBV, HCV, and
HSV-2 using commercial ELISA kits.
Results: The prevalence of IgG antibodies to HSV-2 was 20.8% in STI patients compared to 12.4% in
the general population. The HBV carriage rate was 3.4% in STI patients against 2.9% in the general
population. HCV prevalence was 3.9% in STI patients and 4.6% in the general population. No HIV
infection was found in the study population.
Conclusions: In view of the high prevalence of viral STIs in the tribal community of Central India,
there is a need to strengthen the STI control program in this under-privileged group.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Sexually transmitted diseases represent a major public
health problem worldwide, and the advent and increase of
human immunodeficiency virus (HIV) during the last decade
has highlighted the importance of infections spread by the* Corresponding author. Tel.: +91 761 2370800/818;
fax: +91 761 2672835.
E-mail address: drvgrao@rediffmail.com (V.G. Rao).
1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.03.021sexual route.1 In most developing countries, the incidence
and prevalence of sexually transmitted infections (STIs) may
be 20 times higher than those in developed countries.2
Viral STIs are incurable and may be infectious even when
symptoms are not present.3 Chronic infections with HIV,
hepatitis B virus (HBV), and hepatitis C virus (HCV) are major
public health problems,4 since they are responsible for AIDS
(HIV) and cirrhosis of the liver and hepatocellular carcinoma
(HBV and HCV). Herpes simplex virus 2 (HSV-2) is now the
most common cause of genital ulceration among the sexually
transmitted diseases.5Published by Elsevier Ltd. All rights reserved.
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India to determine the seroprevalence of sexually trans-
mitted viruses, namely, HIV, HBV, and HSV-2. In addition,
we also screened the population for HCV.
Methods
This community-based study was carried out at the Regional
Medical Research Centre for Tribals, Jabalpur from Septem-
ber 2004 to August 2005. Jabalpur is situated at 230100N,
790560E and a mean altitude of 403 meters above sea level.
The center is located in the tribal belt of Central India and
mainly conducts research on the tribal population. The tribal
population is a group of people sharing common cultural and
socio-religious beliefs, residing in a particular geographic
area and practicing endogamy. They are an underprivileged
group of society, having poor access to the health delivery
system.
The study population comprised 326 tribal individuals in
the age group 15—49 years, attending the camp clinic and
having at least one STI. Clinical examination and standard
microbiological tests were performed to diagnose the STI.
Speculum examination was also performed in female
patients. We also studied 526 randomly selected, healthy
tribal adults not having an STI from the same area. For this,
we enumerated the population (15—49 years of age) of
randomly selected study villages. A random sample of 20%
was drawn and included in the study. Demographic, socio-
cultural, and risk behavior information was collected from
study individuals. The survey instruments included a pre-
coded questionnaire and were used in the field after pre-
testing by trained investigators. Written informed consent
was obtained from the study individuals before collecting
blood samples. Pretest counseling for HIV testing
was given. Approximately 5 ml blood was collected by
venipuncture. Sera were separated on site by centrifuga-
tion, aliquoted and transported to the laboratory main-
taining the cold chain. These were stored frozen until
tested.
Serum samples were tested for HIV, HBV, HCV, and HSV-2
using commercial ELISA kits. The samples were tested for
HIV using World Health Organization (WHO) Strategy II.
ELISA was performed using Biotest HIV Tetra ELISA HIV 1
& 2 (Biotest AG, Germany). Sera positive by first ELISA were
tested by rapid tests: Immunocomb II Bispot HIV-1/HIV-2
(Orgenetics Ltd, Israel) or Capillus HIV-1/HIV-2 assay (Tri-
nity Biotech, USA). HSV-2 reactivity was studied by using
UBI Magiwel enzyme immunoassay. Hepatitis B surfaceTable 1 Prevalence of HBV carriage, HIV infection, anti-HCV ant
Study population Gender HBsAg n (%)
(95% C.I.)
ant
(95
STI patients Male (n = 117) 5 (4.3) (1.5—9) 7
Female (n = 209) 6 (2.9) (1.1—5.7) 6
Total (n = 326) 11 (3.4) (1.8—5.7) 13
Randomly
selected
population
Male (n = 274) 11 (4.0) (2.0—6.8) 17
Female (n = 252) 4 (1.6) (0.5—3.6) 7
Total (n = 526) 15 (2.9) (1.6—4.5) 24
STI, sexually transmitted infection; C.I., confidence interval.antigen was detected using the commercially available
ELISA test Hepalisa (J Mitra). anti-HCV antibodies were
tested using Microlisa (J Mitra). An internal quality
check was done by retesting all positive and 5% negative
samples.
Data were entered in Microsoft Excel. The Chi-square test
was used as the test of significance; 95% confidence intervals
were calculated. The study was approved by the institutional
ethics committee of the center.
Results and discussion
We studied 852 serum samples from two different groups
from the tribal population of Jabalpur district. The first group
constituted 326 STI patients (117 male and 209 female). The
second group consisted of 526 age- and sex-matched healthy
tribal individuals (274 male and 252 female) selected ran-
domly from tribal villages by house-to-house survey. All the
surveyed villages are predominantly inhabited by the Gond
tribal population.
The prevalence of IgG antibodies to HSV-2 was 20.8% in STI
patients compared to 12.4% in the general population. The
difference was statistically significant (Chi-square = 11.04,
p < 0.001). The HSV-2 reactivity in males was 11.9% in STI
patients and 7.3% in the general population. This difference
was not statistically significant (Chi-square = 2.24, p > 0.05).
In female STI patients, HSV-2 reactivity was 25.8%, while in
females selected at random, it was 17.9% (Table 1). This
difference was statistically significant (Chi-square = 4.31,
p < 0.05). In a study carried out in Mysore, India, a seropo-
sitivity of 11.3% was seen among young married women.6
Similarly, a study carried out in Bangladesh showed a pre-
valence of 7.9% to 15.4% in different groups.7 The results are
similar to those obtained in a Korean study, which showed a
prevalence of 21.9% in STI clinic attendees.3 A study con-
ducted among women attending a genitourinary medicine
clinic in London8 showed a prevalence of 26%, while a study
carried out in bar and hotel workers of Tanzania9 showed HSV-
2 prevalence of 56.3%. A study carried out in South India
showed a prevalence of 1.2% in the general population.10
The HBV carriage rate was 3.4% in STI patients, against
2.9% in the general population. This difference was not
statistically significant (Chi-square = 0.18, p > 0.05). Studies
carried out in STI patients in other parts of India have
shown HBV carriage rates of 6.2% in Maharashtra,11 2.9% in
North India,4 and 25.9% in South India.12
The anti-HCV prevalence was higher in the general
population (4.6%) than in the STI patients (3.9%). However,ibodies, and anti-HSV-2 antibodies in the study groups
i-HCV n (%)
% C.I.)
anti-HSV-2 n (%)
(95% C.I.)
anti-HIV n (%)
(95% C.I.)
(6.0) (2.6—11.2) 14 (12.0) (6.9—18.6) 0 (0) (0—2.5)
(2.9) (1.1—5.7) 54 (25.8) (20.2—32.0) 0 (0) (0—1.4)
(4.0) (2.2—6.4) 68 (20.9) (16.6—25.4) 0 (0) (0—0.9)
(6.2) (3.7—9.4) 20 (7.3) (4.6—10.8) 0 (0.0) (0—1.0)
(2.8) (1.2—5.3) 45 (17.9) (13.5—22.9) 0 (0.0) (0.0—1.1)
(4.6) (3.0—6.6) 65 (12.4) (9.7—15.3) 0 (0.0) (0—0.6)
Table 2 Prevalence of HBV carriage, anti-HCV antibodies, and anti-HSV-2 antibodies in STI patients by age and sex
Age group
(years)
No. of
individuals
HBsAg anti-HCV anti-HSV-2
Males Females Males n (%) Females n (%) Males n (%) Females n (%) Males n (%) Females n (%)
15—24 16 27 1 (6.3) 0 (0) 2 (12.5) 1 (3.7) 3 (18.8) 15 (55.6)
25—34 44 76 2 (4.5) 2 (2.6) 3 (6.8) 3 (3.9) 6 (13.6) 19 (25.0)
35—44 44 81 2 (4.5) 3 (3.7) 1 (2.3) 1 (1.2) 4 (9.1) 11 (13.6)
45—49 13 25 0 (0) 1 (4.0) 1 (7.7) 1 (4.0) 1 (7.7) 9 (36.0)
Total 117 209 5 (4.3) 6 (2.9) 7 (6.0) 6 (2.9) 14 (12.0) 54 (25.8)
STI, sexually transmitted infection.
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square = 0.16, p > 0.05). This prevalence is similar to that
obtained (4.2%) in a study carried out in Chennai.12 However,
a North Indian study showed a very low (1%) HCV prevalence
in STI clinic attendees.4
The prevalences of anti-HSV-2 and HBsAg were higher in
STI patients as compared to the general population. This
situation was reversed in the case of anti-HCV antibodies. A
possible reason could be that the role of a sexual route in
the transmission of HBV and HSV-2 is proven, while it
remains controversial in the case of HCV.13 Table 2 shows
the prevalence of the infections by age and sex. All the
infections were more common in the 15—24 years age
group. Females in this age group showed HSV-2 reactivity
of 55.6%.
Among the STI patients, three were infected with
both HBV and HCV, while four were infected with both
HBV and HSV-2. In the general population, three indiv-
iduals had HBV and HSV-2 infections, while one had HCV
and HSV-2 infections. No individual had all the three
infections.
No HIV infection was found in the study population. The
reason for this could be that this population belongs to the
tribal belt of Central India where there is lack of big industry,
urbanization, and designated areas for commercial sex work-
ers.14 Further, there are no reports of intravenous drug abuse
or homo/bisexuality, important predisposing factors for
acquiring the infection.
This study shows the presence of various viral STIs, espe-
cially HSV-2, in the tribal community of Central India.
Although the viral STIs are incurable, their prevalence in
the community reflects the degree of risk for STIs. In view of
the high prevalence of viral STIs in the tribal community of
Central India, there is a need to strengthen the STI control
program in this under-privileged group.
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